본문 바로가기
KERD
논문KCI 등재

脾氣虛證 환자의 식사 전후 주관적 식욕과 Gut Hormone 혈중 농도에 대한 탐색적 연구

Exploratory Study on the Pre-and Post-Prandial Subjective Appetite and Plasma Gut Hormone Levels in Spleen Qi Deficiency (SQD) Syndrome

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류한의학

초록

ObjectivesThe aim of this study was to investigate clinical factors of SQD syndrome by tracking plasma gut hormone (active ghrelin, active Glucagon-like peptide-1(GLP-1), pancreatic polypeptide(PP), total peptide YY(PYY)) profiling of pre-post prandial standard meal between SQD group and normal group. MethodsA total of 24 adult participants were consecutively recruited on April 2014. They were diagnosed as either by SQD syndrome or normal by Spleen Qi Deficiency Questionnaire (SQDQ). On the experimental day, blood samplings of 2 ml were repeatedly collected at 6 points from 2 groups for measuring plasma levels of gut hormones. At every point, subjective appetite sensations were self-registered. Results & Conclusions1. There were significantly lower subjective ‘Appetite’ (p=0.012) and higher ‘Satiety’ (p=0.012) in SQD group. At each time point, subjective ‘Appetite’ was significantly lower at 60 min after breakfast (p=0.034) and ‘Satiety’ were significantly higher at 15 min (p=0.020) and 120 min (p=0.044) after breakfast in SQD group. 2. There were no significant differences in plasma levels of gut hormones (active ghrelin, active GLP-1, PP, total PYY) between SQD and normal group. Also at each time point, there were no significant differences of plasma levels of gut hormones between SQD and normal group. 3. Changes in plasma levels of gut hormones compared to baseline were not significantly different at each time point between SQD and normal group. Plasma PYY levels compared to baseline increased in SQD group following 15 min and 30 min after breakfast but decreased in normal group. 4. Further investigation is needed to construct gut hormone profiling and in this perspective, we can approach evaluation tool on variable appetite in Traditional Korean Medicine (TKM) syndrome in the future.

Abstract

ObjectivesThe aim of this study was to investigate clinical factors of SQD syndrome by tracking plasma gut hormone (active ghrelin, active Glucagon-like peptide-1(GLP-1), pancreatic polypeptide(PP), total peptide YY(PYY)) profiling of pre-post prandial standard meal between SQD group and normal group. MethodsA total of 24 adult participants were consecutively recruited on April 2014. They were diagnosed as either by SQD syndrome or normal by Spleen Qi Deficiency Questionnaire (SQDQ). On the experimental day, blood samplings of 2 ml were repeatedly collected at 6 points from 2 groups for measuring plasma levels of gut hormones. At every point, subjective appetite sensations were self-registered. Results & Conclusions1. There were significantly lower subjective ‘Appetite’ (p=0.012) and higher ‘Satiety’ (p=0.012) in SQD group. At each time point, subjective ‘Appetite’ was significantly lower at 60 min after breakfast (p=0.034) and ‘Satiety’ were significantly higher at 15 min (p=0.020) and 120 min (p=0.044) after breakfast in SQD group. 2. There were no significant differences in plasma levels of gut hormones (active ghrelin, active GLP-1, PP, total PYY) between SQD and normal group. Also at each time point, there were no significant differences of plasma levels of gut hormones between SQD and normal group. 3. Changes in plasma levels of gut hormones compared to baseline were not significantly different at each time point between SQD and normal group. Plasma PYY levels compared to baseline increased in SQD group following 15 min and 30 min after breakfast but decreased in normal group. 4. Further investigation is needed to construct gut hormone profiling and in this perspective, we can approach evaluation tool on variable appetite in Traditional Korean Medicine (TKM) syndrome in the future.

참고문헌 (9)

  1. 정한솔, "脾氣虛로 인한 內濕의 발생과 四君子湯", 동의생리병리학회지, 24(6), pp.903~906 (2010), 한의병리학회
  2. Teaching material compilation committee of oriental pathology, "Oriental pathology", pp.411~414 (2008), Hanuimunhwasa
  3. Neary MT, "Gut hormones : implications for the treatment of obesity", Pharmacol Ther, 124(1), pp.44~56 (2009)
  4. Lee JH, "Suggestion of new possibilities in approaching individual variability in appetite through constitutional typology: a pilot study", BMC Complementary and Alternative Medicine, 12, pp.122~ (2012)
  5. 오혜원, "脾氣虛證 진단평가도구 개발 연구", 대한한의학회지, 35(1), pp.157~170 (2014), 대한한의학회
  6. The annual report on the Traditional Korean Medicine R&D Project, Ministry of Health & Welfare (The Modeling of Gut Hormone Profiling of Spleen Qi Deficiency Pattern and the Development of Efficacy Evaluation Technique of Related Herbal Medicine (HI13C0623)), "Lee JH", 31~36 (2014)
  7. Bailly N, "The Dutch Eating Behaviour Questionnaire (DEBQ). Assessment of eating behaviour in an aging French population", Appetite, 59(3), pp.853~858 (2012)
  8. Wren AM, "Gut hormones and appetite control", Gastroenterology, 132(6), pp.2116~2130 (2007)
  9. Rachel CT, "The future role of gut hormones in the treatment of obesity", Ther Adv Chronic Dis, 5(1), pp.4~14 (2014)

관련 논문AI추천

이 간행물의 다른 논문 (13건)